This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): 4E10
Description: Prana has identified amonoclonal antibody, 4E10 which targets a proprietary pathological Abetatarget epitope but not the normal, endogenous Abeta.
Pink Sheet FDA Performance Tracker: CBER Approvals
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Pink Sheet US FDA, Advisory Committees Rarely Disagree
Additional information available to subscribers only: